CRISPR Therapeutics AG (CRSP) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $3.51M | -90.6% |
| 2024 | $37.31M | -89.9% |
| 2023 | $371.21M | +30885.5% |
| 2022 | $1.20M | -99.9% |
| 2021 | $914.96M | +127154.9% |
| 2020 | $719.0K | -99.8% |
| 2019 | $289.59M | +9169.8% |
| 2018 | $3.12M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $3.51M | -90.6% |
| 2024 | $37.31M | -89.9% |
| 2023 | $371.21M | +30885.5% |
| 2022 | $1.20M | -99.9% |
| 2021 | $914.96M | +127154.9% |
| 2020 | $719.0K | -99.8% |
| 2019 | $289.59M | +9169.8% |
| 2018 | $3.12M | — |